ValenTx Competitors and Similar CompaniesClear all
ValenTx's competitors and similar companies include AptamiR Therapeutics, Cell MedX, Tandem Diabetes Care and GI Windows.
 ValenTx ValenTx is an early-stage medical device company developing a non-surgical, implantable medical therapy to treat obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. |  AptamiR Therapeutics AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders. |  Cell MedX Cell MedX Corp. is an early development stage company focused on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications. |  Tandem Diabetes Care Tandem Diabetes Care is a medical device company that engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. |  GI Windows GI Windows is a clinical-stage medical device company specializing in non-surgical treatment of type-2 diabetes and obesity. | |
Founding Date | Founding Date 2002 | Founding Date 2012 | Founding Date 2014 | Founding Date 2006 | Founding Date 2012 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Maple Grove, US HQ | Locations Austin, US HQ | Locations Carson City, US HQ | Locations San Diego, US HQ Markham, CA Schiphol, NL | Locations Westwood, US HQ |
Employees | Employees 10 | Employees N/A | Employees 150% decrease | Employees 2,65010% increase | Employees 244% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 8.5 m | Valuation ($) 2.2 b | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($566.3k) (FY, 2025) | Net income ($204.7m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 10.3m (over 7 years ago) | Latest funding round $ 3m (over 10 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 16.4m (almost 6 years ago) |
Total funding raised | Total funding raised $ 38.1m | Total funding raised $ 3m | Total funding raised N/A | Total funding raised $ 401.5m | Total funding raised $ 42.9m |
For sources of this data, please see the company profile
View Company Profiles
AptamiR Therapeutics
HQ
Austin, US
AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders.
View companyCell MedX
HQ
Carson City, US
Employees
1↓ 50% decrease
Cell MedX Corp. is an early development stage company focused on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes by developing technologies to help manage the illness and related complications.
View companyTandem Diabetes Care
HQ
San Diego, US
Employees
2,650↑ 10% increase
Tandem Diabetes Care is a medical device company that engages in the design, development, and commercialization of products for people with insulin-dependent diabetes.
View companyGI Windows
HQ
Westwood, US
Employees
24↑ 4% increase
GI Windows is a clinical-stage medical device company specializing in non-surgical treatment of type-2 diabetes and obesity.
View company